Oruka Therapeutics ORKA
NASDAQ ORKA
$82.15 -2.04 (-2.42%)
At close: Sep 29, 2026 · 4:00 PM EDT

Oruka Therapeutics (ORKA) Current Assets (2010 - 2026)

Updated

Oruka Therapeutics (ORKA) posted Current Assets of $884.56 million for Q2 2026, up 166.4% from $332.01 million a year earlier and up 123.8% from the prior quarter.

Analysis

Oruka Therapeutics (ORKA) Current Assets (2010 - 2026) Analysis & Trends

At the end of FY2025, Oruka Therapeutics' Current Assets came in at $343.86 million, down 8.8% from FY2024.

  • Annual Current Assets shows a five-year compound annual growth rate of 47.1% (FY2020 to FY2025).
  • In prior years, Oruka Therapeutics' Current Assets was $376.87 million in FY2024 (+902.5%), $37.59 million in FY2023 (-12.0%), $42.7 million in FY2022 (-21.5%) and $54.42 million in FY2021 (+8.9%).
  • The Q2 2026 figure stands as the highest quarterly Current Assets in data going back to Q4 2010.
  • On a year-over-year basis, Current Assets increased in six of the last eight quarters, with growth averaging 470.3%.
  • The strongest year-over-year quarter for Current Assets in the past five years was Q3 2024, with growth of 961.8%; the weakest was Q1 2022, with a decline of 26.5%.
  • According to Business Quant data, Current Assets for the three prior quarters was $395.25 million (Q1 2026), $343.86 million (Q4 2025) and $355.16 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 59.77 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.67 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 27.97 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 13.95 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 12.54 Bn
10 Oruka Therapeutics 5.29 Bn 3.34 Bn - 884.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 884.56 Mn
Mar 31, 2026 395.25 Mn
Dec 31, 2025 343.86 Mn
Sep 30, 2025 355.16 Mn
Jun 30, 2025 332.01 Mn
Mar 31, 2025 352.08 Mn
Dec 31, 2024 376.87 Mn
Sep 30, 2024 412.95 Mn
Jun 30, 2024 33.82 Mn
Mar 31, 2024 36.67 Mn
Dec 31, 2023 37.59 Mn
Sep 30, 2023 38.89 Mn
Jun 30, 2023 40.76 Mn
Mar 31, 2023 41.70 Mn
Dec 31, 2022 42.70 Mn
Sep 30, 2022 44.55 Mn
Jun 30, 2022 47.66 Mn
Mar 31, 2022 50.54 Mn
Dec 31, 2021 54.42 Mn
Sep 30, 2021 59.67 Mn
API Access

Oruka Therapeutics Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=ORKA&period=max&api_key=YOUR_API_KEY